[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586455":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":88,"collaborators":92,"id":115,"slug":116,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":121,"eligibilityCriteria":122,"healthyVolunteers":117,"sex":123,"minAge":124,"maxAge":10,"enrollmentInfo":125,"targetDuration":128,"studyType":129,"phases":10,"briefSummary":130,"conditions":131,"keywords":133,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":148},{"fullName":5,"class":6},"Kutahya Health Sciences University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Coronary artery disease",null,"Patients with coronary artery disease who were treated with drug coated balloons will be included in the study.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Fatih Kahraman, Associate Professor","CONTACT","+905442764616","fatih.kahraman@ksbu.edu.tr",[19,39,56,66,76],{"facility":20,"status":21,"city":22,"state":10,"zip":10,"country":23,"countryCode":10,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Pamukkale University","RECRUITING","Denizli","Turkey (Türkiye)",{"type":25,"coordinates":26},"Point",[27,28],29.0875,37.77417,{"lat":28,"lon":27},[31,35],{"name":32,"role":15,"phone":33,"phoneExt":10,"email":34},"Ismail D Kilic, Professor","+905326434948","idogukilic@pau.edu.tr",{"name":36,"role":15,"phone":37,"phoneExt":10,"email":38},"Mehmet Kilinc, MD","5073505984","klncmehmet@hotmail.com",{"facility":40,"status":21,"city":41,"state":10,"zip":10,"country":23,"countryCode":10,"cosmosGeoPoint":42,"geoPoint":46,"contacts":47},"Bahcelievler Memorial Hospital","Istanbul",{"type":25,"coordinates":43},[44,45],28.94966,41.01384,{"lat":45,"lon":44},[48,52],{"name":49,"role":15,"phone":50,"phoneExt":10,"email":51},"Omer Goktekin, Professor","5323252371","ogoktekin@gmail.com",{"name":53,"role":15,"phone":54,"phoneExt":10,"email":55},"Hasim Tuner, MD","5456176667","hasimtuner@gmail.com",{"facility":57,"status":21,"city":41,"state":10,"zip":10,"country":23,"countryCode":10,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"Bezmialem Vakıf Universitesi",{"type":25,"coordinates":59},[44,45],{"lat":45,"lon":44},[62],{"name":63,"role":15,"phone":64,"phoneExt":10,"email":65},"Mahmut Uluganyan, Professor","5055853534","uluganyan@gmail.com",{"facility":67,"status":21,"city":41,"state":10,"zip":10,"country":23,"countryCode":10,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"Goztepe Medicalpark Hastanesi",{"type":25,"coordinates":69},[44,45],{"lat":45,"lon":44},[72],{"name":73,"role":15,"phone":74,"phoneExt":10,"email":75},"Adnan Kaya, Professor","5324009765","adnankaya@ymail.com",{"facility":77,"status":21,"city":78,"state":10,"zip":10,"country":23,"countryCode":10,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Kutahya City Hospital","Kütahya",{"type":25,"coordinates":80},[81,82],29.98333,39.42417,{"lat":82,"lon":81},[85],{"name":14,"role":15,"phone":86,"phoneExt":10,"email":87},"5442764616","drfkahraman@hotmail.com",{"type":89,"investigatorFullName":90,"investigatorTitle":91,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Fatih Kahraman","Associate Professor",[93,94,96,98,100,102,104,106,108,111,113],{"name":20,"class":6},{"name":95,"class":6},"Memorial Bahçelievler Hospital",{"name":97,"class":6},"Bezmialem Vakif University",{"name":99,"class":6},"Dicle University",{"name":101,"class":6},"Ordu University",{"name":103,"class":6},"Adana City Training and Research Hospital",{"name":105,"class":6},"Marmara University",{"name":107,"class":6},"Trakya University",{"name":109,"class":110},"Kafkas University Health Research and Application Hospital","UNKNOWN",{"name":112,"class":6},"Selcuk University",{"name":114,"class":6},"Istanbul University - Cerrahpasa","100586455","drug-coated-coronary-balloons-in-different-clinical-scenarios-100586455",false,"NCT06915597","Drug-Coated Coronary Balloons in Different Clinical Scenarios","Procedural Success and Short- and Long-Term Outcomes of Drug-Coated Coronary Balloons Used in Different Clinical Scenarios","DCB-DCS","Inclusion Criteria:\n\nAge ≥18 years. Patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) in whom a drug-coated balloon (DCB) is used as the intended treatment strategy for at least one target lesion.\n\nDCB use in any clinical presentation, including stable coronary artery disease and acute coronary syndromes.\n\nDCB treatment for different lesion subsets, including de novo lesions, in-stent restenosis, bifurcation lesions, small and large vessels, and chronic total occlusions.\n\nSuccessful lesion preparation allowing DCB angioplasty (residual stenosis ≤30% and absence of flow-limiting dissection before DCB inflation, according to operator judgment).\n\nAvailability of baseline clinical, angiographic, and procedural data. Ability to provide informed consent for prospective enrollment or availability of data according to local regulations for retrospective inclusion.\n\nPlanned clinical follow-up.\n\nExclusion Criteria:\n\nPrimary treatment strategy without the use of a drug-coated balloon (e.g., exclusive drug-eluting stent implantation without DCB).\n\nCardiogenic shock at the time of index procedure. Life expectancy less than 1 year due to non-cardiac comorbidities. Contraindication to antiplatelet therapy. Known severe allergy to contrast media not amenable to premedication. Pregnancy. Inability to comply with clinical follow-up. Participation in another interventional clinical trial that could confound outcome assessment.","ALL","18 Years",{"count":126,"type":127},1500,"ESTIMATED","1 Year","OBSERVATIONAL","Coronary stents are the best treatment method ever accepted in the treatment of coronary artery stenoses. Due to some limitations and complications of stent use, the operators tried to find new solutions. Drug Coated Balloons (DCBs) have been accepted as a new method in the treatment of in-stent restenosis and small vessel disease. Furthermore, they have been used in the treatment of de novo coronary lesions, chronic total occlusions and bifucation lesions. But data is limited in the short and long term success of DCBs in all these clinical scenarios. In our study we aimed to investigate the procedural success and short and long term outcomes of DCB use in different clinical scenarios.",[132],"Coronary Arterial Disease (CAD)",[134,135,136,137,138],"drug coted balloons","coronary artery disease","chronic total occlusions","de novo lesions","small vessel disease","2026-01-11",{"date":141,"type":142},"2026-01-13","ACTUAL",{"date":144,"type":142},"2025-05-31",{"date":146,"type":127},"2026-05-31",{"name":5,"class":6},5]